Reviva Pharmaceuticals Holdings, Inc. Unrecognized Tax Benefits, Period Increase (Decrease)
Reviva Pharmaceuticals Holdings, Inc. (RVPH) reported Unrecognized Tax Benefits, Period Increase (Decrease) of $900.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-03.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease · last filed 2025-04-03
- Reviva Pharmaceuticals Holdings, Inc. unrecognized tax benefits, period increase (decrease) for fiscal 2024 was $900.00K, a 28.57% increase from fiscal 2023.
- Reviva Pharmaceuticals Holdings, Inc. unrecognized tax benefits, period increase (decrease) for fiscal 2023 was $700.00K.
| Period end | Unrecognized Tax Benefits, Period Increase (Decrease) 12 month |
|---|---|
| 2024-12-31 | $900.00K 10-K · filed 2025-04-03 |
| 2023-12-31 | $700.00K 10-K · filed 2025-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |